Next Article in Journal
Towards the Identification of New Genes Involved in ABA-Dependent Abiotic Stresses Using Arabidopsis Suppressor Mutants of abh1 Hypersensitivity to ABA during Seed Germination
Next Article in Special Issue
Facile Synthesis of FeCo/Fe3O4 Nanocomposite with High Wave-Absorbing Properties
Previous Article in Journal
A Labile Pool of IQGAP1 Disassembles Endothelial Adherens Junctions
Previous Article in Special Issue
Preparation of Novel Poly(hydroxyethyl methacrylate-co-glycidyl methacrylate)-Grafted Core-Shell Magnetic Chitosan Microspheres and Immobilization of Lactase
Int. J. Mol. Sci. 2013, 14(7), 13391-13402; doi:10.3390/ijms140713391
Article

Apoferritin Modified Magnetic Particles as Doxorubicin Carriers for Anticancer Drug Delivery

1
,
1
,
1
,
1,2
,
1
,
1,2
,
3
,
4
,
1,2
 and
1,2,*
1 Department of Chemistry and Biochemistry, Faculty of Agronomy, Mendel University in Brno, Zemedelska 1, Brno CZ-613 00, Czech Republic 2 Central European Institute of Technology, Brno University of Technology, Technicka 3058/10, Brno CZ-616 00, Czech Republic 3 Department of Biochemistry, Faculty of Science, Charles University, Albertov 2030, Prague 2 CZ-128 40, Czech Republic 4 Department of Paediatric Haematology and Oncology, 2nd Faculty of Medicine and University Hospital Motol, Charles University, V Uvalu 84, Prague 5 CZ-150 06, Czech Republic
* Author to whom correspondence should be addressed.
Received: 19 April 2013 / Revised: 18 May 2013 / Accepted: 23 May 2013 / Published: 27 June 2013
(This article belongs to the Special Issue Magnetic Nanoparticles 2013)
View Full-Text   |   Download PDF [1865 KB, uploaded 19 June 2014]   |  

Abstract

Magnetic particle mediated transport in combination with nanomaterial based drug carrier has a great potential for targeted cancer therapy. In this study, doxorubicin encapsulation into the apoferritin and its conjugation with magnetic particles was investigated by capillary electrophoresis with laser-induced fluorescence detection (CE-LIF). The quantification of encapsulated doxorubicin was performed by fluorescence spectroscopy and compared to CE-LIF. Moreover, the significant enhancement of the doxorubicin signal was observed by addition of methanol into the sample solution.
Keywords: cancer; nanomedicine; magnetic particles; doxorubicin; nanoparticles cancer; nanomedicine; magnetic particles; doxorubicin; nanoparticles
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).
SciFeed

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote |
RIS
MDPI and ACS Style

Blazkova, I.; Nguyen, H.V.; Dostalova, S.; Kopel, P.; Stanisavljevic, M.; Vaculovicova, M.; Stiborova, M.; Eckschlager, T.; Kizek, R.; Adam, V. Apoferritin Modified Magnetic Particles as Doxorubicin Carriers for Anticancer Drug Delivery. Int. J. Mol. Sci. 2013, 14, 13391-13402.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert